Medical Innovation Competition
Competition Purpose and Scope
The ICMIC aims to identify and promote outstanding startups developing innovative products and services for cerebro-cardiovascular health. Entrants are nominated by co-organising institutions as winners and finalists from leading innovation programmes and competitions. The principal feature of ICMIC is the live bidding deal-making, whereby finalists present concise, timed pitches. Industry leaders and investors may then express non-binding interests in collaboration or investment. A multidisciplinary panel of judges—including Expert Review Panel: experts in scientific research, engineering, clinical medicine, regulatory affairs, and Investment Judging Panel: industry leaders and investors—provides comprehensive assessment and constructive feedback throughout the event.
Competition Pitching Session Procedure
Each finalist project will take part in a dynamic session designed to promote deal flow and knowledge exchange:
Pitch Presentation
(5 minutes)
Project teams will present their solutions and business case.
Expert Q&A
(4 minutes)
An interactive discussion with the Expert Review Panel (composed of scientific, medical, and engineering professionals), to evaluate the project’s scientific, clinical, and regulatory aspects.
Deal-Making Session
(6 minutes)
The Investment Judging Panel (composed of leading industry professionals and investors) may offer oral investment or collaboration proposals or share constructive suggestions directly with the teams. This session aims to encourage immediate connections, actionable outcomes, and valuable guidance.
After the Event:
Oral investment or collaboration proposals are encouraged to emerge during the live deal-making session. We also welcome participants and judging panel members to use a non-binding Letter of Intent (LOI) to formally record mutual interest.
Judging Panel Composition
Panellists will provide structured feedback and may express interest in future collaboration, including the potential signing of Letters of Intent (LOIs) with selected teams, subject to mutual agreement. A clear scoring rubric helps ensure a fair, transparent evaluation for all participants.
Expert Review Panel Members
Prof. Peter B. BARKER
Prof. Guanshu LIU
Prof. Yu WANG
Prof. Xinge YU
Dr. Alice CHENG
Prof. Alison NOBLE
Prof. Ed X. WU
Mr. Tony YUNG
Prof. Qi DOU
Dr. Chau-Minh PHAN
Prof. Joseph T.K. WU
Prof. Tongyu ZHU
Prof. Peter JEZZARD
Dr. Stanley K.F. TAM
Prof. Chenjie XU
Investment Judging Panel Members
Dr. Chandler CHEN
Ms. Scarlett CHEN
Mr. Fred LI
Mr. Franco PANG
Recognition & Collaboration Opportunities
Outstanding teams will receive:
• ICMIS 2025 Medical Innovation Competition Plaques (Golden, Silver, and Bronze), presented by Judging panel representatives during the summit in front of an international audience of clinicians, investors, and industry leaders.
• Opportunities for individual collaboration, including the potential signing of Letters of Intent (LOIs) between investment judging panel members and selected project teams, for further discussion of investment or strategic partnerships, subject to mutual interest and agreement.
This competition is designed not only to showcase breakthrough cerebro-cardiovascular innovations, but also to catalyse real-world partnerships, pilots, and investment discussions.